Day: February 16, 2017

There is significant lack of diversity in clinical trial populations. FDA approved 67 new drugs in 2015 and 2016, and of the total trial populations, 5-7% were African-Americans, 11-12% were Asians, while 76-79% were White. Women were more equally represented with about 40-48% study populations being female. The situation was worse in certain indications like … Read more

Recently “Right to Try” bills were introduced in the US Senate and Congress. Similar laws have been enacted in 33 states; however it was felt that creating a Federal law will have a stronger impact in getting companies to give experiment drugs to terminally ill patients. While the intent behind the bills is great, the … Read more